Chassatide C11

General Information


DRACP ID  DRACP00400

Peptide Name   Chassatide C11

Sequence  IPCGESCVWIPCISGMFGCSCKDKVCYS

Sequence Length  28

UniProt ID  C0HKH6 

PubChem CID  Not available

Origin  Chassalia chartacea

Type  Native peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=1.2 μM MTT assay Not available 1

Hemolytic Activity  Human erythrocytes: HD50=13.3 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00400

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys19; Cys7<--->Cys21; Cys12<--->Cys26

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H199N31O38S7

Absent amino acids  AHLNQRT

Common amino acids  C

Mass  349839

Pl  6.03

Basic residues  2

Acidic residues  2

Hydrophobic residues  7

Net charge  0

Boman Index  63

Hydrophobicity  60.71

Aliphatic Index  62.5

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  7365

Absorbance 280nm  272.78

Polar residues  14

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22467870

Title  Novel cyclotides and uncyclotides with highly shortened precursors from Chassalia chartacea and effects of methionine oxidation on bioactivities

Doi 10.1074/jbc.M111.338970

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4289

DRACP is developed by Dr.Zheng's team.